MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$27,538K
Net loss
-$25,967K
Dividend attributable to
down round feature of...
$1,571K
Other income, net
$345K
Loss from operations
-$26,312K
Research and development
$14,540K
General and
administrative
$11,772K
Back
Back
Income Statement
source: myfinsight.com
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)